Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05251402 · ClinicalTrials.gov registry record · Phase 2
Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern
A Phase 2 study of Asthma, sponsored by University of Illinois at Chicago.
- Active
- Registry status
- Phase 2
- Development phase
- 323
- Enrollment target
- 2
- Study locations
NCT05251402 is a Phase 2 study of Asthma that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 323 participants, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT05251402, a Phase 2 study of Asthma, is active but no longer recruiting, sponsored by University of Illinois at Chicago.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 323 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the ALOHA trial is to investigate the efficacy of improved diet quality following a DASH behavioral intervention that has shown promising results in adults with uncontrolled asthma. DASH stands for Dietary Approaches to Stop Hypertension. This healthy diet is known to help people with high blood pressure manage their health. But physicians do not know if the DASH diet can also benefit patients with uncontrolled asthma. Researchers in the ALOHA study are trying to find out the answer to this important question. Researchers at UIC are studying how 2 asthma care programs compare in terms of helping adults with uncontrolled asthma to improve their quality of life. Researchers also want to learn what might explain the differences in patient outcomes that they may see between the 2 programs. The primary outcome will be asthma-specific quality of life. If the DASH behavioral intervention is found to benefit people with uncontrolled asthma, it would provide a practical, safe, and acceptable public-health intervention in the form of dietary modification to reduce the burden of asthma.
Conditions Studied
Interventions
- BEHAVIORAL Group A - Patient Education
- BEHAVIORAL Group B - Patient Education with Nutrition Counseling
Study Locations (2)
Illinois
- Department of Medicine - Chicago
- UIC CCTS Clinical Research Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 323 participants |
| Start Date | 2022-03-09 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05251402
The ClinicalTrials.gov registry entry for NCT05251402 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 323 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,562-participant average among 374 other Asthma trials with a reported enrollment target (79% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Group A - Patient Education is the first listed.
NCT05251402 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT05251402 about?
NCT05251402 is a clinical study titled "Addressing Quality of Life, Clinical Outcomes, and Mechanisms in Uncontrolled Asthma Following the DASH Dietary Pattern". The goal of the ALOHA trial is to investigate the efficacy of improved diet quality following a DASH behavioral intervention that has shown promising results in adults with uncontrolled asthma. DASH stands for Dietary Approaches to Stop Hypertension. This healthy diet is known to help people with hi...
What is the current status of trial NCT05251402?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 323 participants. The study started on 2022-03-09. Estimated completion is 2026-09-01.
What conditions does trial NCT05251402 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT05251402?
The interventions under investigation include: Group A - Patient Education (BEHAVIORAL), Group B - Patient Education with Nutrition Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT05251402?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05251402 being conducted?
This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.